Literature DB >> 29505317

Genital warts treatment: Beyond imiquimod.

Jianwei Yuan1, Guoying Ni2, Tianfang Wang3, Kate Mounsey2, Shelley Cavezza2, Xuan Pan1, Xiaosong Liu1,2.   

Abstract

Genital warts are one of the most common sexually transmitted diseases worldwide. The disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 and 11. Current therapies for genital warts are mainly ablative, or alternatively topical application of imiquimod cream and sinecatechin (polyphenon E) ointment to the warts. However, low patient compliance and high recurrence rate are significant problems for the treatment of genital warts by imiquimod and ablative therapies. We summarise recent literature in this area and propose combining imiquimod with other therapies to increase the efficacy of imiquimod.

Entities:  

Keywords:  early protein 7; genital warts; imiquimod; interleukin 10

Mesh:

Substances:

Year:  2018        PMID: 29505317      PMCID: PMC6067868          DOI: 10.1080/21645515.2018.1445947

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  60 in total

Review 1.  Imiquimod in clinical practice.

Authors:  L Edwards
Journal:  J Am Acad Dermatol       Date:  2000-07       Impact factor: 11.527

2.  Sexually transmitted disease quarterly report: anogenital warts and anogenital herpes simplex virus infection in England and Wales.

Authors: 
Journal:  Commun Dis Rep CDR Wkly       Date:  2000-06-30

Review 3.  Host-defense peptides of Australian anurans. Part 2. Structure, activity, mechanism of action, and evolutionary significance.

Authors:  John H Bowie; Frances Separovic; Michael J Tyler
Journal:  Peptides       Date:  2012-07-03       Impact factor: 3.750

4.  The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

Authors:  P Barnard; N A McMillan
Journal:  Virology       Date:  1999-07-05       Impact factor: 3.616

5.  The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida.

Authors:  H Wong; J H Bowie; J A Carver
Journal:  Eur J Biochem       Date:  1997-07-15

Review 6.  Using imiquimod for genital warts in female patients.

Authors:  J Thomas Cox; Karl-Ulrich Petry; Eva Rylander; Michel Roy
Journal:  J Womens Health (Larchmt)       Date:  2004-04       Impact factor: 2.681

7.  Low prevalence of oral and nasal human papillomavirus in employees performing CO2-laser evaporation of genital warts or loop electrode excision procedure of cervical dysplasia.

Authors:  Kristian Kofoed; Christina Norrbom; Ola Forslund; Charlotte Møller; Ligita P Frøding; Anders Elm Pedersen; Algirdas Markauskas; Maria Blomberg; Jane Baumgartner-Nielsen; Jakob Torp Madsen; Gitte Strauss; Klaus G Madsen; Carsten Sand
Journal:  Acta Derm Venereol       Date:  2015-02       Impact factor: 4.437

8.  Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes.

Authors:  Kathryn H Richards; Rosella Doble; Christopher W Wasson; Mohammed Haider; G Eric Blair; Miriam Wittmann; Andrew Macdonald
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

9.  Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity.

Authors:  Janin Chandra; Yan Miao; Natasha Romoff; Ian H Frazer
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

10.  NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells.

Authors:  Hani Alrefai; Khalid Muhammad; Ronald Rudolf; Duong Anh Thuy Pham; Stefan Klein-Hessling; Amiya K Patra; Andris Avots; Valesca Bukur; Ugur Sahin; Stefan Tenzer; Matthias Goebeler; Andreas Kerstan; Edgar Serfling
Journal:  Nat Commun       Date:  2016-05-25       Impact factor: 14.919

View more
  4 in total

1.  Topical application of temperature-sensitive caerin 1.1 and 1.9 gel inhibits TC-1 tumor growth in mice.

Authors:  Bowei Ma; Jianwei Yuan; Shu Chen; Kunsong Huang; Qianbo Wang; Jianchun Ma; Ruoting Lin; Lu Zhang; Yingying Zhou; Tianfang Wang; Shelley F Walton; Xuan Pan; Guoqiang Chen; Yuejian Wang; Guoying Ni; Xiaosong Liu
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

Review 2.  HPV infection in urology practice.

Authors:  Mehmet Sarier; Ali Murat Ceyhan; Nevgun Sepin; Esin Ozel; Mehmet Murat Inal; Erdal Kukul; Ahmet Soylu
Journal:  Int Urol Nephrol       Date:  2019-10-03       Impact factor: 2.370

Review 3.  Penile warts: an update on their evaluation and management.

Authors:  Alexander Kc Leung; Benjamin Barankin; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2018-12-19

Review 4.  The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics.

Authors:  Janice García-Quiroz; Bismarck Vázquez-Almazán; Rocío García-Becerra; Lorenza Díaz; Euclides Avila
Journal:  Cells       Date:  2022-08-15       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.